Immunogenicity and efficacy of Ad26. COV2 .S: An adenoviral vector–based COVID ‐19 vaccine
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and efficacy of Ad26.
COV2
.S: An adenoviral vector–based
COVID
‐19 vaccine
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-06-11
DOI
10.1111/imr.13088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021
- (2022) Isaac See et al. ANNALS OF INTERNAL MEDICINE
- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
- (2022) Seong Jin Choi et al. Cellular & Molecular Immunology
- Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant
- (2022) Malcolm Risk et al. CLINICAL INFECTIOUS DISEASES
- Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
- (2022) Sue Ann Costa Clemens et al. LANCET
- Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
- (2022) Jinyan Liu et al. NATURE
- The T cell immune response against SARS-CoV-2
- (2022) Paul Moss NATURE IMMUNOLOGY
- Homologous and Heterologous Covid-19 Booster Vaccinations
- (2022) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina
- (2022) Dan-Yu Lin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
- (2022) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-COV-2 Variants: Differences and Potential of Immune Evasion
- (2022) Sandro M. Hirabara et al. Frontiers in Cellular and Infection Microbiology
- Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
- (2022) Wael Bahnan et al. Frontiers in Immunology
- Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
- (2022) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa
- (2022) Glenda Gray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge
- (2022) Jennifer M. Polinski et al. JAMA Network Open
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine
- (2021) Nadine C. Salisch et al. ANNALS OF INTERNAL MEDICINE
- Racial Disparities in COVID-19 Testing and Outcomes
- (2021) Gabriel J. Escobar et al. ANNALS OF INTERNAL MEDICINE
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
- (2021) Kathryn E. Stephenson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients
- (2021) Huanle Luo et al. Frontiers in Immunology
- Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020
- (2021) Lyudmyla Kompaniyets et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
- (2021) Isaac See et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- (2021) Andreas Greinacher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
- (2021) Jessica R. MacNeil et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
- (2021) Jackson S. Turner et al. NATURE
- Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia
- (2021) Angela Huynh et al. NATURE
- Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
- (2021) Galit Alter et al. NATURE
- CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
- (2021) Erin M. Bange et al. NATURE MEDICINE
- Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
- (2021) Dan H. Barouch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hybrid immunity
- (2021) Shane Crotty SCIENCE
- Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
- (2021) Shamus P. Keeler et al. Viruses-Basel
- Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
- (2021) Lyudmyla Kompaniyets et al. Preventing Chronic Disease
- Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
- (2021) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset
- (2021) Ariel Karlinsky et al. eLife
- Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
- (2021) Shaun J. Grannis et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
- (2021) Andreas Greinacher et al. BLOOD
- Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner
- (2021) Roanne Keeton et al. Cell Host & Microbe
- Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
- (2021) Thibault Fiolet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mechanisms underpinning poor antibody responses to vaccines in ageing
- (2021) Jia Le Lee et al. IMMUNOLOGY LETTERS
- Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
- (2021) Alasdair P S Munro et al. LANCET
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
- (2021) Leo Swadling et al. NATURE
- Covid-19 Vaccine Effectiveness in New York State
- (2021) Eli S. Rosenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Neutralization of the SARS-CoV-2 Omicron Variant
- (2021) Fabian Schmidt et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
- (2021) Barbara A. Cohn et al. SCIENCE
- High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
- (2021) Kathryn A. Pape et al. Cell Reports
- ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome
- (2021) Alexander T. Baker et al. Science Advances
- Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
- (2021) Juan Corchado-Garcia et al. JAMA Network Open
- Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington
- (2020) Temet M. McMichael et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
- (2020) John Allotey et al. BMJ-British Medical Journal
- Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
- (2020) Stephanie L. Harrison et al. PLOS MEDICINE
- Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 — United States, May–August 2020
- (2020) Jeremy A.W. Gold et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
- (2020) Rinke Bos et al. npj Vaccines
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania
- (2019) Zacchaeus Anywaine et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
- (2014) N. Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now